EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION

Cappato R., Ezekowitz M.D., Klein A.L., et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation // Eur. heart J. – 2014. Sep. 2. [Epub ahead of print].

Saved in:
Bibliographic Details
Format: Article
Language:Russian
Published: Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2016-03-01
Series:Неотложная медицинская помощь
Online Access:https://www.jnmp.ru/jour/article/view/128
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849410495367348224
collection DOAJ
description Cappato R., Ezekowitz M.D., Klein A.L., et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation // Eur. heart J. – 2014. Sep. 2. [Epub ahead of print].
format Article
id doaj-art-c48032512cf04e3cb1fcae8c65d26cea
institution Kabale University
issn 2223-9022
2541-8017
language Russian
publishDate 2016-03-01
publisher Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
record_format Article
series Неотложная медицинская помощь
spelling doaj-art-c48032512cf04e3cb1fcae8c65d26cea2025-08-20T03:35:06ZrusSklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare DepartmentНеотложная медицинская помощь2223-90222541-80172016-03-01046667126EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSIONCappato R., Ezekowitz M.D., Klein A.L., et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation // Eur. heart J. – 2014. Sep. 2. [Epub ahead of print].https://www.jnmp.ru/jour/article/view/128
spellingShingle EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
Неотложная медицинская помощь
title EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
title_full EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
title_fullStr EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
title_full_unstemmed EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
title_short EXPLORE THE EFFICACY AND SAFETY OF ONCE-DAILY ORAL RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION SCHEDULED FOR CARDIOVERSION
title_sort explore the efficacy and safety of once daily oral rivaroxaban for the prevention of cardiovascular events in patients with non valvular atrial fibrillation scheduled for cardioversion
url https://www.jnmp.ru/jour/article/view/128